- Home
- COLL vs LOMA Comparison
COLL vs LOMA Comparison
Compare COLL & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- LOMA
- Stock Information
- Founded
- COLL 2002
- LOMA 1926
- Country
- COLL United States
- LOMA Argentina
- Employees
- COLL 357
- LOMA N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- LOMA Building Materials
- Sector
- COLL Health Care
- LOMA Industrials
- Exchange
- COLL Nasdaq
- LOMA Nasdaq
- Market Cap
- COLL 1.1B
- LOMA 916.1M
- IPO Year
- COLL 2015
- LOMA 2017
- Fundamental
- Price
- COLL $34.62
- LOMA $10.35
- Analyst Decision
- COLL Strong Buy
- LOMA Strong Buy
- Analyst Count
- COLL 4
- LOMA 2
- Target Price
- COLL $44.25
- LOMA $15.00
- AVG Volume (30 Days)
- COLL 319.8K
- LOMA 862.1K
- Earning Date
- COLL 11-06-2025
- LOMA 11-06-2025
- Dividend Yield
- COLL N/A
- LOMA N/A
- EPS Growth
- COLL N/A
- LOMA N/A
- EPS
- COLL 1.06
- LOMA 0.37
- Revenue
- COLL $707,007,000.00
- LOMA $559,741,122.00
- Revenue This Year
- COLL $21.29
- LOMA $22.92
- Revenue Next Year
- COLL $3.36
- LOMA $25.84
- P/E Ratio
- COLL $32.88
- LOMA $28.50
- Revenue Growth
- COLL 22.61
- LOMA N/A
- 52 Week Low
- COLL $23.23
- LOMA $7.04
- 52 Week High
- COLL $39.95
- LOMA $14.17
- Technical
- Relative Strength Index (RSI)
- COLL 49.72
- LOMA 68.71
- Support Level
- COLL $34.46
- LOMA $7.47
- Resistance Level
- COLL $35.90
- LOMA $10.82
- Average True Range (ATR)
- COLL 0.97
- LOMA 0.53
- MACD
- COLL 0.19
- LOMA 0.39
- Stochastic Oscillator
- COLL 69.18
- LOMA 80.22
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.